Blue Trust Inc. Has $16.54 Million Stock Position in HCA Healthcare, Inc. (NYSE:HCA)

Blue Trust Inc. lifted its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 1.1% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 40,700 shares of the company’s stock after acquiring an additional 448 shares during the period. Blue Trust Inc.’s holdings in HCA Healthcare were worth $16,542,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of HCA. Stratos Investment Management LLC raised its holdings in HCA Healthcare by 52.2% during the third quarter. Stratos Investment Management LLC now owns 991 shares of the company’s stock worth $403,000 after buying an additional 340 shares during the last quarter. Aaron Wealth Advisors LLC increased its holdings in HCA Healthcare by 46.7% during the 3rd quarter. Aaron Wealth Advisors LLC now owns 1,514 shares of the company’s stock worth $615,000 after purchasing an additional 482 shares in the last quarter. V Square Quantitative Management LLC boosted its position in shares of HCA Healthcare by 3.0% during the third quarter. V Square Quantitative Management LLC now owns 3,741 shares of the company’s stock valued at $1,520,000 after buying an additional 110 shares during the last quarter. Sax Wealth Advisors LLC lifted its stake in HCA Healthcare by 14.8% during the 3rd quarter. Sax Wealth Advisors LLC now owns 1,187 shares of the company’s stock valued at $482,000 after acquiring an additional 153 shares in the last quarter. Finally, Sumitomo Mitsui DS Asset Management Company Ltd grew its stake in shares of HCA Healthcare by 3.7% in the 3rd quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 22,729 shares of the company’s stock worth $9,238,000 after acquiring an additional 809 shares in the last quarter. 62.73% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on the company. StockNews.com raised HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Monday, July 1st. Wells Fargo & Company raised their price target on HCA Healthcare from $315.00 to $365.00 and gave the stock an “equal weight” rating in a report on Tuesday, July 30th. Truist Financial increased their price target on shares of HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a report on Monday, August 19th. Morgan Stanley assumed coverage on shares of HCA Healthcare in a research note on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 target price on the stock. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $392.00 price target on shares of HCA Healthcare in a report on Tuesday, October 1st. Five research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and four have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $365.65.

HCA Healthcare Stock Up 2.3 %

Shares of HCA stock opened at $415.67 on Friday. The company has a quick ratio of 0.94, a current ratio of 1.06 and a debt-to-equity ratio of 27.11. The stock has a market cap of $108.87 billion, a P/E ratio of 20.72, a PEG ratio of 1.44 and a beta of 1.67. HCA Healthcare, Inc. has a 52 week low of $215.96 and a 52 week high of $417.14. The company’s fifty day simple moving average is $392.18 and its two-hundred day simple moving average is $350.18.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.97 by $0.53. The company had revenue of $17.49 billion for the quarter, compared to the consensus estimate of $17.05 billion. HCA Healthcare had a net margin of 8.40% and a return on equity of 553.13%. HCA Healthcare’s revenue was up 10.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $4.29 earnings per share. Analysts predict that HCA Healthcare, Inc. will post 22.51 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, September 30th. Stockholders of record on Monday, September 16th were issued a $0.66 dividend. The ex-dividend date was Monday, September 16th. This represents a $2.64 annualized dividend and a dividend yield of 0.64%. HCA Healthcare’s dividend payout ratio (DPR) is presently 13.16%.

Insiders Place Their Bets

In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of the company’s stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the transaction, the executive vice president now directly owns 29,678 shares in the company, valued at $11,438,494.76. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,857 shares of the business’s stock in a transaction dated Thursday, July 25th. The stock was sold at an average price of $355.05, for a total transaction of $659,327.85. Following the sale, the senior vice president now owns 17,755 shares in the company, valued at approximately $6,303,912.75. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Michael S. Cuffe sold 8,358 shares of the firm’s stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the transaction, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at $11,438,494.76. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 17,202 shares of company stock worth $6,407,273 over the last quarter. Company insiders own 1.60% of the company’s stock.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.